Chylomicrons enhance endotoxin excretion in

Chylomicrons prevent endotoxin toxicity and increase endotoxin uptake by hepatocytes. As a consequence, less endotoxin is available to activate macrophages, thereby reducing tumor necrosis factor secretion. To determine whether the chylomicron-mediated increase in hepatocellular uptake of endotoxin results in increased endotoxin excretion into bile, we examined bile after endotoxin administration. A sublethal dose (7 pg/kg) of 1251-endotoxin was incubated with either rat mesenteric lymph containing nascent chylomicrons (500 mg of chylomicron triglyceride per kg of body weight) or an equal volume of normal saline (controls) for 3 h and then infused into male Sprague-Dawley rats. Bile samples were collected via a common bile duct catheter for 24 h. Infusion of endotoxin incubated with chylomicrons increased biliary excretion of endotoxin by 67% at 3 h (P 5 0.006) and by 20% at 24 h (P c 0.01) compared with infusion of endotoxin incubated in saline. Endotoxin activity, as measured by the Limulus assay, was not detected in the bile of test animals. However, endotoxin activity was detected after hot phenol-water extraction of bile, demonstrating that endotoxin is inactive in the presence of bile but retains bioactivity after hepatic processing. Since the majority of an intravenous endotoxin load has been shown to be cleared by the liver, acceleration of hepatocyte clearance and biliary excretion of endotoxin may represent a component of the mechanism by which chylomicrons protect against endotoxin-induced lethality. Endotoxemia stimulates changes in lipid metabolism, including an increase in plasma triglyceride (TG) (1, 13, 19, 26, 57). It has been proposed that the hypertriglyceridemia observed during gram-negative sepsis represents the mobilization of fat stores to fuel the body's metabolic response to the infectious challenge (3, 7, 30). However, there is data to suggest that TG-rich lipoproteins are components of the acute-phase response. One of the earliest and most consistent metabolic responses to endotoxin is an increase in plasma TG levels due to an increase in TG-rich very-low-density lipoprotein (VLDL) (13). This endotoxin-stimulated hypertriglyceridemia may have a protective function, since TG-rich lipoproteins (VLDL and chylomicrons) have been shown to bind endotoxin and inhibit its activity (11, 20, 21, 53). We have demonstrated that chylomicrons and VLDL, when incubated with lethal doses of endotoxin prior to intraperitoneal administration, inhibit detection of endotoxin by the Limulus assay in vitro (11, 20) and protect mice from death (21). Chylomicrons also prevent death in rats when given intravenously prior to a dose of endotoxin (22). In …

[1]  J. Hoofnagle,et al.  Lymphokines and bile secretion in the rat. , 2008, Liver.

[2]  H. Harris,et al.  Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. , 1993, The Journal of clinical investigation.

[3]  K. Feingold,et al.  Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.

[4]  P. Brandtzaeg,et al.  Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. , 1992, The Journal of clinical investigation.

[5]  K. Emancipator,et al.  In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins , 1992, Infection and immunity.

[6]  H. Harris,et al.  Chylomicrons can inhibit endotoxin activity in vitro. , 1991, The Journal of surgical research.

[7]  K. Feingold,et al.  Tumor necrosis factor, cytokines, and the hyperlipidemia of infection , 1991, Trends in Endocrinology & Metabolism.

[8]  H. Harris,et al.  Detection of endotoxin in triglyceride-rich lipoproteins in vitro. , 1991, The Journal of laboratory and clinical medicine.

[9]  J. Swaney,et al.  High density lipoprotein subpopulations from galactosamine-treated rats and their transformation by lecithin:cholesterol acyltransferase. , 1991, Journal of lipid research.

[10]  H. Harris,et al.  Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. , 1990, The Journal of clinical investigation.

[11]  J. Cavaillon,et al.  Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide , 1990, Infection and immunity.

[12]  A. Wendel,et al.  Studies on the hepatotoxicity of galactosamine/endotoxin or galactosamine/TNF in the perfused mouse liver. , 1990, Biochemical pharmacology.

[13]  M. Meza,et al.  Colchicine prevents D-galactosamine-induced hepatitis. , 1989, Journal of hepatology.

[14]  D. Morrison,et al.  The physical-chemical characterization and biologic activity of serum released lipopolysaccharides. , 1988, Journal of immunology.

[15]  J. Berliner,et al.  Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. , 1988, The Journal of clinical investigation.

[16]  H. S. Warren,et al.  Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum. , 1986, The Journal of infectious diseases.

[17]  R. Munford,et al.  Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. , 1986, Science.

[18]  P. Edwards,et al.  The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Beutler,et al.  Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. , 1985, Journal of immunology.

[20]  C. Galanos,et al.  Alterations in rats in vivo of the chemical structure of lipopolysaccharide from Salmonella abortus equi. , 1985, European journal of biochemistry.

[21]  R. Munford,et al.  Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat. , 1985, The Journal of infectious diseases.

[22]  C. Galanos,et al.  Excretion of radioactivity in faeces and urine of rats injected with 3H,14C-lipopolysaccharide. , 1985, British journal of experimental pathology.

[23]  J. H. Shaw,et al.  Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. , 1985, The American journal of physiology.

[24]  C. Galanos,et al.  Distribution and localization of endotoxin in the reticulo-endothelial system (RES) and in the main vessels of the rat during shock. , 1985, Pathology, research and practice.

[25]  R. Havel,et al.  Uptake and processing of remnants of chylomicrons and very low density lipoproteins by rat liver. , 1984, Journal of lipid research.

[26]  C. Galanos,et al.  The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule. , 1984, Reviews of infectious diseases.

[27]  J. Stuart,et al.  An improved chromogenic substrate endotoxin assay for clinical use. , 1983, Journal of clinical pathology.

[28]  P. Tso,et al.  Intestinal lipoproteins in the rat with D-(+)-galactosamine hepatitis. , 1983, Journal of lipid research.

[29]  J. Lipton,et al.  Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. , 1982, The Journal of clinical investigation.

[30]  A. Cerami,et al.  Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Knook,et al.  Clearance capacity of rat liver Kupffer, Endothelial, and parenchymal cells. , 1981, Gastroenterology.

[32]  N. Kaplowitz,et al.  The hepatocellular uptake and biliary excretion of endotoxin in the rat , 1981, Hepatology.

[33]  E. Wisse,et al.  Uptake by liver cells of endotoxin following its intravenous injection. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[34]  R. Ulevitch,et al.  New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. , 1981, The Journal of clinical investigation.

[35]  R. Ulevitch,et al.  New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. , 1979, The Journal of clinical investigation.

[36]  R. Ulevitch,et al.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. , 1979, Journal of immunology.

[37]  R. Ulevitch,et al.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. , 1978, The Journal of clinical investigation.

[38]  R. Ulevitch The preparation and characterization of a radioiodinated bacterial lipopolysaccharide. , 1978, Immunochemistry.

[39]  G. Blackburn Lipid metabolism in infection. , 1977, The American journal of clinical nutrition.

[40]  E. Masoro Fat metabolism in normal and abnormal states. , 1977, The American journal of clinical nutrition.

[41]  S. Sabesin,et al.  Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury , 1975, Science.

[42]  E. Ribi,et al.  PHYSICAL ASPECTS OF REVERSIBLE INACTIVATION OF ENDOTOXIN * , 1966, Annals of the New York Academy of Sciences.

[43]  A. Braude,et al.  Studies with Radioactive Endotoxin. II. Correlation of Physiologic Effects with Distribution of Radioactivity in Rabbits Injected with Lethal Doses of E. Coli Endotoxin Labelled with Radioactive Sodium Chromate , 1955 .

[44]  O. Lüderitz,et al.  Über die Extraktion von Bakterien mit Phenol/Wasser , 1952 .

[45]  C. Galanos,et al.  Metabolic fate of endotoxin in rat. , 1990, Advances in experimental medicine and biology.

[46]  S. Sabesin,et al.  Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. , 1989, Journal of lipid research.

[47]  E. Wisse,et al.  Cultured Kupffer cells, isolated from human and rat liver biopsies, ingest endotoxin. , 1988, Journal of hepatology.

[48]  E. Wisse,et al.  Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. , 1988, Journal of hepatology.

[49]  G. Ramadori,et al.  Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. , 1984, The American journal of emergency medicine.

[50]  D. Keppler,et al.  Galactosamine induced liver injury. , 1972, Progress in liver diseases.

[51]  D. Keppler,et al.  Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. , 1971, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.